News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Intersect ENT Announces Positive Results From Pilot Study of Novel In-Office Implant for Chronic Sinusitis Patients


9/30/2013 10:59:17 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MENLO PARK, Calif. & VANCOUVER, British Columbia--(BUSINESS WIRE)--Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and throat clinicians and their patients, today reported findings from a prospective U.S. multi-center pilot study to evaluate the feasibility, safety and efficacy of the company’s newest steroid delivery implant for patients suffering from the debilitating symptoms of chronic sinusitis. Results were presented at the Annual American Rhinologic Society Meeting in Vancouver, Canada, and were recognized by the society with the Cottle Award for Best Clinical Science Research. \

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES